Optimi Health Requests Final Inspection for Dealer’s License
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or...
Day: December 7, 2021
SmileDirectClub Partners with Celebrity Cosmetic Dentist Dr. Amira Ogunleye To Advocate for Increased Access to Oral Care
Dr. Amira Ogunleye Dr. Amira Ogunleye, a celebrity cosmetic dentist and oral care thought leader, will partner with SmileDirectClub to...
Iovance Biotherapeutics to Present at Upcoming Conferences
SAN CARLOS, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel...
Skylight Health Announces Closing of Public Offering of 275,000 Shares of Series A Cumulative Redeemable Perpetual Preferred Stock
TORONTO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a...
Innovative Inhaled Drug Delivery Developer Aerami Therapeutics to Merge with Special Purpose Acquisition Company FoxWayne Enterprises Acquisition Corp. to Become Public Company
New entity poised to accelerate the development of Aerami’s diverse pipeline ofnext-generation inhaled therapies AER-901, Aerami’s proprietary inhaled, nebulized formulation...
Resonant to Present at the Oppenheimer 5G Summit on December 14, 2021
AUSTIN, Texas, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions...
Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of Strategic Sales and Business Development
Bush to lead Predictive Oncology’s novel sales effort towards cancer research technologies Pamela Bush SVP of Strategic Sales & Business...
Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card
Company’s Director Nominees are Highly Qualified and Experienced with Track Records of Guiding Early-Stage Life Science Companies Executing Strategy to...
Maple Leaf Green World Inc. Enters China’s Health and Wellness Market By Forming A New JV Company with Beijing Forest Eco
CALGARY, Alberta, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”), (CSE: MGW)...
Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19
No Published Viral Mutations to Date, Including Omicron Variant, Meaningfully Impact the Regions of the Viral Genome Targeted by the...
Digipath Takes Over Management & Signs Letter of Intent to Acquire Majority Control of Steep Hill’s Licensed Northern California Lab from Evio Labs
Acquisition Would Extend Multi-State Operator (MSO) Strategy LAS VEGAS, NV, Dec. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Digipath,...
ALR Technologies and Infinovo Sign Memorandum of Understanding to Manufacture World’s First CGM for Diabetic Pets
SINGAPORE, Dec. 07, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, is...
Pharvaris Announces Changes to its Board of Directors
ZUG, Switzerland, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization...
ZAGENO’s New Operations Leader Delivers Consumer Expertise from Apple
Kostas Sereleas Senior VP of Operations at ZAGENO CAMBRIDGE, Mass., Dec. 07, 2021 (GLOBE NEWSWIRE) -- ZAGENO, a leading enterprise...
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
NEW YORK and SOLANA BEACH, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Cyprium Therapeutics, Inc. (“Cyprium”), a Fortress Biotech, Inc....
PepGen Appoints Vice President of Program Management and Promotes Sonia Bracegirdle, Ph.D., to Senior Vice President, Strategy & Operations
Dr. Bracegirdle to lead expanded PepGen Strategy and Operations teamIsami J. Salcedo, experienced biotechnology operations and program management professional, joins...
Recce Pharmaceuticals Announces Update on Phase I/II Clinical Trial for the Treatment of Burn Wound Infections
Highlights: Broad spectrum antibiotic activity on bacterial burn wound infections with visible infection reduction <24 hours on all patients to...
Gain Therapeutics Progresses Krabbe Disease Program and Provides Scientific Update
Data Show Statistically Significant Increases in GALC Enzyme and Depletion of Toxic Substrate PsychosineBETHESDA, Md., Dec. 07, 2021 (GLOBE NEWSWIRE) --...
Aligos Presents Update of Chronic Hepatitis B Pipeline Portfolio at HEP DART 2021
New data from HBeAg-positive patients receiving 100 mg of ALG-000184 demonstrates similar PK and potent antiviral activity to previously reported...
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma
PALO ALTO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address...
